Cardio Sleep Dental Solutions Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 593 Cranbury Rd, East Brunswick, NJ 08816 Phone: 732-254-5999 Fax: 732-257-5606 |
Dental Arts Studio Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 15 W Prospect St, East Brunswick, NJ 08816 Phone: 732-254-5600 |
Dr. Jeffrey S. Karlin, P.a. Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 17 Brunswick Woods Dr, East Brunswick, NJ 08816 Phone: 732-238-1110 Fax: 732-238-0792 |
Dental Arts Studio Dentist Medicare: Not Enrolled in Medicare Practice Location: 15 W Prospect St, East Brunswick, NJ 08816 Phone: 732-254-5600 Fax: 732-254-5651 |
Revolutionary Brier Hill Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: E7 Brier Hill Ct, East Brunswick, NJ 08816 Phone: 732-239-0565 |
Irvin B Sherman, Dds, Pa Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 176 Summerhill Rd, East Brunswick, NJ 08816 Phone: 732-257-5588 Fax: 732-257-9189 |
East Brunswick New Image Dental Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 444 Ryders Ln, East Brunswick, NJ 08816 Phone: 732-432-8388 Fax: 732-432-8366 |
Spotswood Family Dental Llc. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2 Auer Ct Ste C, East Brunswick, NJ 08816 Phone: 732-251-6010 Fax: 732-251-6016 |
Ac Dental Of Nj, Inc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 300 Route 18, East Brunswick, NJ 08816 Phone: 732-254-9000 Fax: 732-254-1999 |
Cranbury Dental Services Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: E8 Brier Hill Ct, East Brunswick, NJ 08816 Phone: 732-390-9093 Fax: 732-390-9383 |
News Archive
Moffitt Cancer Center and CvergenX, Inc., announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™. Researchers at Moffitt have used gene expression analysis and systems biology to create a radio-sensitivity classification index for individual tumors.
Bristol-Myers Squibb Company and Pfizer today reported that the companies have discontinued the Phase 3 APPRAISE-2 clinical trial in patients with recent Acute Coronary Syndrome (ACS) treated with apixaban or placebo in addition to mono or dual antiplatelet therapy.
When the pros and cons of prostate cancer treatment are spelled out using an online interactive program developed by Thomas Jefferson University researchers, more patients choose active surveillance over therapy, according to research being presented Wednesday (October 23rd) at the Society for Medical Decision Making annual meeting in Baltimore, Maryland.
An algorithm developed at the Hebrew University cuts through the immense number of possible solutions to shorten drug discovery times from years to months.
› Verified 7 days ago